Your session is about to expire
← Back to Search
Real RepetitiveTranscranial Magnetic Stimulation (rTMS) 5 sessions for Endometriosis
Study Summary
This trial aims to improve pain outcomes for Canadian women with endometriosis. It will test the effectiveness of a repetitive transcranial magnetic stimulation (rTMS) intervention for reducing pain in individuals
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who is eligible to participate in this clinical investigation?
"To be eligible for participation in this study, individuals must have a diagnosis of endometriosis and fall between the ages of 18 and 40. The trial aims to recruit approximately 152 participants."
What specific objectives does this medical study aim to fulfill?
"The primary target of this clinical investigation, observed for approximately 30 days post-intervention, is the Numeric Rating Scale (NRS) to document daily pain levels. Supplementary objectives encompass Perceived Pain Intensity (PPI), which involves applying an algometer device to assess perceived pain intensity based on prior pressure thresholds obtained from each participant at all designated sites. Following pressure application, participants will rate their discomfort using a numerical scale ranging from 0 to 10. Additionally, adherence to the treatment protocol entails monitoring attendance at repetitive transcranial magnetic stimulation (rTMS) sessions. Lastly, the Beck Depression Inventory-II (BDI-II)"
Is the enrollment process open for this medical study at present?
"As per information from clinicaltrials.gov, this particular trial is currently not accepting new participants. It was initially posted on April 1st, 2024, and last revised on March 26th, 2024. Despite the inactive status of this study, it's essential to note that there are a substantial number of 458 ongoing clinical trials actively seeking eligible candidates."
Are individuals above the age of 50 eligible to participate in this research trial?
"This trial is open to individuals aged above 18 years and below 40 years."
Share this study with friends
Copy Link
Messenger